Laparoscopic Sleeve Gastrectomy in Patients with Left Ventricular Assist Device-Case Series and Review of Literature.
Bridge to transplant
Heart failure
Heart transplant
LVAD
Laparoscopic sleeve gastrectomy
Obesity
Ventricular support
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
1
5
2020
medline:
15
4
2021
entrez:
1
5
2020
Statut:
ppublish
Résumé
For patients with advanced heart failure, left ventricular assist device (LVAD) can serve as a bridge to heart transplantation. Patients with class II obesity are eligible for implantation of LVAD but do not meet criteria for cardiac transplant listing. Laparoscopic sleeve gastrectomy (LSG) is proposed as weight losing modality in order to reach the New York Heart Association (NYHA) criteria for listing. In our center, three patients on LVAD with need for weight-reducing therapy were treated with laparoscopic sleeve gastrectomy. We reviewed our data retrospectively and compared it with the literature. Successful weight loss was achieved in all patients, without postoperative adverse events. Two out of three were listed on transplant waiting list. Our results are similar to those described in other series.
Identifiants
pubmed: 32350711
doi: 10.1007/s11695-020-04642-w
pii: 10.1007/s11695-020-04642-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3628-3633Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35(1):1–23.
doi: 10.1016/j.healun.2015.10.023
Clerkin KJ, Naka Y, Mancini DM, et al. The impact of obesity on patients bridged to transplantation with continuous-flow left ventricular assist devices. JACC Hear Fail. 2016;4(10):761–8.
doi: 10.1016/j.jchf.2016.05.010
Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–91.
doi: 10.1001/jama.2016.6458
Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32.
doi: 10.1016/j.jacc.2008.12.068
Horwich TB, Broderick S, Chen L, et al. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol. 2011;108(12):1754–9.
doi: 10.1016/j.amjcard.2011.07.051
Kenchaiah S, Pocock SJ, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007;116(6):627–36.
doi: 10.1161/CIRCULATIONAHA.106.679779
Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305–13.
doi: 10.1056/NEJMoa020245
Zhai AB, Haddad H. The impact of obesity on heart failure. Curr Opin Cardiol. 2017;32:196–202.
doi: 10.1097/HCO.0000000000000370
Kindel TL, Strande JL. Bariatric surgery as a treatment for heart failure: review of the literature and potential mechanisms. Surg Obes Relat Dis. 2018;14(1):117–22.
doi: 10.1016/j.soard.2017.09.534
Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail. 2017;19:595–602.
doi: 10.1002/ejhf.779
Emani S, Brewer RJ, John R, et al. Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist device. J Heart Lung Transplant. 2013;32(1):31–5.
doi: 10.1016/j.healun.2012.09.024
Bray GA, Frühbeck G, Ryan DH, et al. Management of obesity. Lancet. 2016;387:1947–56.
doi: 10.1016/S0140-6736(16)00271-3
Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–34.
doi: 10.1111/joim.12012
Mancini D, Goldsmith R, Levin H, et al. Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices. Circulation. 1998;98(12):1178–83.
doi: 10.1161/01.CIR.98.12.1178
Guerrier JB, Dietch ZC, Schirmer BD, et al. Laparoscopic sleeve gastrectomy is associated with lower 30-day morbidity versus laparoscopic gastric bypass: an analysis of the American College of Surgeons NSQIP. Obes Surg. 2018;28(11):3567–72.
doi: 10.1007/s11695-018-3396-4
Khan MS, Yuzefpolskaya M, Memon MM, et al. Outcomes associated with obesity in patients undergoing left ventricular assist device implantation. ASAIO J. 2019;1 [Internet]. [cited 2019 Nov 12]. Available from: http://insights.ovid.com/crossref?an=00002480-900000000-98662
Akay MH, Nathan SS, Radovancevic R, et al. Obesity is associated with driveline infection of left ventricular assist devices. ASAIO J. 2019;65(7):678–82. [Internet]. [cited 2019 Nov 12]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30398982
doi: 10.1097/MAT.0000000000000916
Lee AY, Tecson KM, Lima B, et al. Durable left ventricular assist device implantation in extremely obese heart failure patients. Artif Organs. 2019;43(3):234–41. [Internet]. [cited 2019 Nov 12]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30357882
doi: 10.1111/aor.13380
Chaudhry UI, Kanji A, Sai-Sudhakar CB, et al. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. Surg Obes Relat Dis. 2015;11(1):88–93.
doi: 10.1016/j.soard.2014.04.003
Leviner DB, Keidar A, Ben-Gal T, et al. Cardiac function recovery following LVAD implantation and bariatric surgery in a morbidly obese patient. J Card Surg. 2014;29(5):740–2.
doi: 10.1111/jocs.12404
Shah SK, Gregoric ID, Nathan SS, et al. Simultaneous left ventricular assist device placement and laparoscopic sleeve gastrectomy as a bridge to transplant for morbidly obese patients with severe heart failure. J Heart Lung Transplant. 2015;34:1489–91. Elsevier USA
doi: 10.1016/j.healun.2015.06.011
Jeng EI, Aranda JM, Ahmed M, et al. Left ventricular assist device and bariatric surgery: a bridge to heart transplant by weight and waiting time reduction. J Card Surg. 2016;31(2):120–2.
doi: 10.1111/jocs.12688
Punchai S, Nor Hanipah Z, Sharma G, et al. Laparoscopic sleeve gastrectomy in heart failure patients with left ventricular assist device. Obes Surg. 2019;29(4):1122–9.
doi: 10.1007/s11695-018-3570-8
Hawkins RB, Go K, Raymond SL, et al. Laparoscopic sleeve gastrectomy in patients with heart failure and left ventricular assist devices as a bridge to transplant. Surg Obes Relat Dis. 2018;14(9):1269–73.
doi: 10.1016/j.soard.2018.04.005
Aittigrine S, Tozzi P, Hullin R, et al. Laparoscopic sleeve gastrectomy for class III obesity in a patient with a left ventricular assist device (LVAD) Heartmate III. Surg Obes Relat Dis. 2019;15(8):1420–1.
doi: 10.1016/j.soard.2019.05.008
Zenilman AL, Camacho DR, Choi J. Scientific session of the 16th world congress of endoscopic surgery, jointly hosted by Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) & Canadian Association of General Surgeons (CAGS), Seattle, Washington, USA, 11-14 April 2018: poster abstracts. Surg Endosc. 2018;32:130–359.
doi: 10.1007/s00464-018-6121-4
Greene J, Tran T, Shope T. Sleeve gastrectomy and left ventricular assist device for heart transplant. JSLS. 2017;21(3)